UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 198

Sortiert nach

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin: A Randomized, Double-Blind, Placebo-Controlled Trial

The New England journal of medicine, 1991-02, Vol.324 (7), p.429-436

1991

Volltextzugriff (PDF)

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial

Critical care medicine, 1998-01, Vol.26 (1), p.15-23

1998

Volltextzugriff (PDF)

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome

Critical care medicine, 2000-09, Vol.28 (9), p.3149-3154

2000

Volltextzugriff (PDF)

Placebo and Inhaled Nitric Oxide Mortality the Same in ARDS Clinical Trial

Critical care medicine, 1998-03, Vol.26 (3), p.619-619

1998

Volltextzugriff (PDF)

Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2004-04, Vol.291 (13), p.1603

2004

Volltextzugriff (PDF)

HA-1A in septic patients with ARDS : results from the pivotal trial

Intensive care medicine, 1994-05, Vol.20 (5), p.328-334

1994

Volltextzugriff (PDF)

Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome

The Journal of pediatrics, 1993-06, Vol.122 (6), p.974-981

1993

Volltextzugriff (PDF)

HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis

Infectious disease clinics of North America, 1992-03, Vol.6 (1), p.253-266

1992

Volltextzugriff (PDF)

Peroxidase-antiperoxidase assay for rapid detection of respiratory syncytial virus in nasal epithelial specimens from infants and children

Journal of Clinical Microbiology, 1987-04, Vol.25 (4), p.722-725

1987

Volltextzugriff (PDF)

Influence of alterations in forgoing life-sustaining treatment practices on a clinical sepsis trial

Critical care medicine, 1997-03, Vol.25 (3), p.383-387

1997

Volltextzugriff (PDF)

Adenovirus type 7b in a children's hospital

The Journal of infectious diseases, 1983-05, Vol.147 (5), p.814

1983

Volltextzugriff (PDF)

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

Critical care medicine, 1992-06, Vol.20 (6), p.864-874

1992

Volltextzugriff (PDF)

Protean manifestations of perinatal enterovirus infections

The Western journal of medicine, 1983-06, Vol.138 (6), p.847

1983

Volltextzugriff (PDF)

From the Bench to the Bedside: The Future of Sepsis Research: Executive Summary of an American College of Chest Physicians, National Institute of Allergy and Infectious Disease, and National Heart, Lung, and Blood Institute Workshop

Chest, 1997-03, Vol.111 (3), p.744-753

Dellinger, R Phillip

1997

Volltextzugriff (PDF)

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

The New England journal of medicine, 1991-02, Vol.324 (7), p.429-436

1991

Volltextzugriff (PDF)

Illness associated with contamination of drinking water supplies with phenol

British medical journal (Clinical research ed.), 1985-06, Vol.290 (6484), p.1800

1985

Volltextzugriff (PDF)

The AIDS epidemic: dilemmas facing nurse managers

Nursing economic, 1986-05, Vol.4 (3), p.109

1986

Volltextzugriff (PDF)

From the Bench to the Bedside: The Future of Sepsis Research

Chest, 1997-03, Vol.111 (3), p.744-753

1997

Volltextzugriff (PDF)

Nitric Oxide: How Varied Standards of Ventilation Affect Study Outcome

Critical care medicine, 1999-04, Vol.27 (4), p.847-847

Papadakos, Peter J

1999

Volltextzugriff (PDF)

Inhaled Nitric Oxide in ARDS: Is the Question Closed?

Critical care medicine, 1999-04, Vol.27 (4), p.846-846

1999

Volltextzugriff (PDF)

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group

Critical care medicine, 1998-01, Vol.26 (1), p.15

1998

Volltextzugriff (PDF)

Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study Group

Critical care medicine, 1997-03, Vol.25 (3), p.383-387

1997

Volltextzugriff (PDF)

Inhaled Nitric Oxide

Critical care medicine, 1999-04, Vol.27 (4), p.848-848

1999

Volltextzugriff (PDF)

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group

Annals of internal medicine, 1994-07, Vol.121 (1), p.1

1994

Volltextzugriff (PDF)

Treatment of septic shock with human monoclonal antibody HA-1A: A randomized, double-blind, placebo-controlled trial

Resuscitation, 1995-08, Vol.30 (1), p.81-82

1995

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(107)
Humans
(103)
Biological And Medical Sciences
(43)
Female
(41)
Male
(39)
Medical Sciences
(33)
Adult
(29)
Middle Aged
(28)
General & Internal Medicine
(24)
Neurosciences & Neurology
(24)
Aged
(21)
Radiology, Nuclear Medicine & Medical Imaging
(19)
Clinical Neurology
(18)
Neurosciences
(17)
Critical Care Medicine
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Old Medline
(13)
Physical Sciences
(13)
Psychiatry
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin: A Randomized, Double-Blind, Placebo-Controlled Trial

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome

Placebo and Inhaled Nitric Oxide Mortality the Same in ARDS Clinical Trial

Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial

HA-1A in septic patients with ARDS : results from the pivotal trial

Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome

HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis

Peroxidase-antiperoxidase assay for rapid detection of respiratory syncytial virus in nasal epithelial specimens from infants and children

Influence of alterations in forgoing life-sustaining treatment practices on a clinical sepsis trial

Adenovirus type 7b in a children's hospital

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

Protean manifestations of perinatal enterovirus infections

From the Bench to the Bedside: The Future of Sepsis Research: Executive Summary of an American College of Chest Physicians, National Institute of Allergy and Infectious Disease, and National Heart, Lung, and Blood Institute Workshop

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

Illness associated with contamination of drinking water supplies with phenol

The AIDS epidemic: dilemmas facing nurse managers

From the Bench to the Bedside: The Future of Sepsis Research

Nitric Oxide: How Varied Standards of Ventilation Affect Study Outcome

Inhaled Nitric Oxide in ARDS: Is the Question Closed?

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group

Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study Group

Inhaled Nitric Oxide

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group

Treatment of septic shock with human monoclonal antibody HA-1A: A randomized, double-blind, placebo-controlled trial

Suchergebnisse filtern